Nordhealth AS - Primary insider notice
Nordhealth AS (NORDH) · publisert 2024-03-21 14:55 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Philippe Vimard 2 a) Position/status The notification concerns a primary insider, board member, Philippe Vimard | The notification concerns a primary insider, board member, Philippe Vimard | acquisition | 88 400 | 27 NOK | 2024-03-21 | NO0011002651 | Euronext Growth Oslo | rules |
Vedlegg
- Nordhealth_AS_Notification_of_transactions_by_Primary_Insiders_Philippe_Vimard_19726894_1.pdf (tekst hentet ut)
Meldingstekst
Helsinki, Finland, 21 March 2024: Philippe Vimard, board member and a primary
insider of Nordhealth AS (the "Company"), has today purchased 88,400 class A
shares in the Company at a price of NOK 27 per share.
Following the transaction, Philippe Vimard owns 88,400 class A shares in the
Company.
Please refer to the attached notification of trading for further details.
For further information, please contact:
Charles MacBain, CEO
charles.macbain@nordhealth.com
+44 75 3903 2200
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with nearly 400 employees
working either remotely or from offices (collaboration hubs). Visit the
company's website at nordhealth.com (http://www.nordhealth.com).